PHH2 — Paul Hartmann AG Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapContrarian

Annual income statement for Paul Hartmann AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,433	2,302	2,312	2,353	2,408
Cost of Revenue
Gross Profit	1,383	1,315	1,310	1,318	1,440
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,270	2,166	2,248	2,291	2,270
Operating Profit	163	135	63.4	62.5	138
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	160	135	60.6	48.9	125
Provision for Income Taxes
Net Income After Taxes	113	97.1	39.5	32.7	114
Minority Interest
Net Income Before Extraordinary Items
Net Income	106	94.7	36.1	28.4	108
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	106	94.7	36.1	28.4	108
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	41.7	28.6	15	14.9	34.5
Dividends per Share